Sinotherapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	155.4	407.11	225.79	641.79	763.15	511.66
Short-Term Investments	-	-	-	107.21	44.09	-
Trading Asset Securities	658.31	339.34	507.74	-	-	-
Cash & Short-Term Investments	813.72	746.45	733.53	749	807.23	511.66
Cash Growth	9.47%	1.76%	-2.07%	-7.21%	57.77%	17.85%
Accounts Receivable	59.05	86.25	110.97	78.47	71.27	44.09
Other Receivables	2.43	3.24	0.3	0.57	-	-
Receivables	61.48	89.49	111.27	79.04	71.27	44.09
Inventory	76.93	72.55	102.42	84.61	29.38	40.43
Other Current Assets	25.78	26.38	29.1	39.36	45.83	22.66
Total Current Assets	977.92	934.87	976.32	952.01	953.71	618.83
Property, Plant & Equipment	361.27	363.88	344.34	271.41	255.92	115.09
Long-Term Investments	86.2	64.27	64.42	64.2	49.1	69.99
Goodwill	16.22	16.22	18.39	18.39	18.39	-
Other Intangible Assets	12.22	14.98	21.65	27.59	32.47	41.16
Long-Term Deferred Tax Assets	18.47	19.01	19.33	14.29	16.45	16.08
Long-Term Deferred Charges	0.29	0.46	0.92	1.21	1.99	3.15
Other Long-Term Assets	2.39	24.41	7.94	12.54	4.3	1.5
Total Assets	1,475	1,438	1,453	1,362	1,332	865.81

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	29.05	19.24	16.75	13.34	8.42	8.01
Accrued Expenses	9.08	12.47	26.49	14.69	11.58	14.19
Current Portion of Leases	-	0.02	0.01	0.06	0.32	0.78
Current Income Taxes Payable	0.92	1.07	6.97	1.28	0.45	7.85
Current Unearned Revenue	36.16	29.91	30.44	48.01	56.8	46.78
Other Current Liabilities	20.7	20.24	22.54	13.33	12.47	11.92
Total Current Liabilities	95.95	82.96	103.19	90.72	90.05	89.52
Long-Term Leases	-	-	-	0.02	1.2	3.66
Long-Term Unearned Revenue	54.05	58.43	74.72	58.09	61.12	64.62
Long-Term Deferred Tax Liabilities	2.18	2.25	2.39	2.53	2.68	2.82
Other Long-Term Liabilities	3.96	2.48	-	-	-	-
Total Liabilities	156.14	146.12	180.3	151.36	155.05	160.62

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	453.34	453.34	453.34	453.34	453.34	408
Additional Paid-In Capital	514.61	512.92	513.57	512.89	512.89	179.23
Retained Earnings	387.08	361.86	342.22	244.16	211.19	118.26
Treasury Stock	-36.13	-36.13	-36.13	-	-	-
Comprehensive Income & Other	-0.05	-0.02	-	-0.13	-0.15	-0.31
Shareholders' Equity	1,319	1,292	1,273	1,210	1,177	705.19
Total Liabilities & Equity	1,475	1,438	1,453	1,362	1,332	865.81

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.04	0.02	0.01	0.09	1.52	4.44
Net Cash (Debt)	813.68	746.43	733.53	748.92	805.71	507.22
Net Cash Growth	9.47%	1.76%	-2.05%	-7.05%	58.85%	16.82%
Net Cash Per Share	1.96	1.73	1.61	1.59	1.91	1.24
Filing Date Shares Outstanding	434.54	449	449	449.15	453.34	408
Total Common Shares Outstanding	434.54	449	449	453.34	453.34	408
Working Capital	881.97	851.91	873.13	861.29	863.66	529.31
Book Value Per Share	3.04	2.88	2.84	2.67	2.60	1.73
Tangible Book Value	1,290	1,261	1,233	1,164	1,126	664.02
Tangible Book Value Per Share	2.97	2.81	2.75	2.57	2.48	1.63
Buildings	-	251.86	216.23	211.68	54.29	52.41
Machinery	-	214.98	183.49	160.89	145.6	135.93
Construction In Progress	-	57.58	80.75	15.35	153.61	4.68